Cargando…
Anti-platelet aggregation of Panax notoginseng triol saponins by regulating GP1BA for ischemic stroke therapy
BACKGROUND: Panax notoginseng triol saponins (PTS) has been used clinically for ischemic stroke therapy (IST) in China for more than 17 years due to its anti-platelet aggregation and neuro-protective effects, but its mechanism of action is not fully understand. In this study, anti-platelet aggregati...
Autores principales: | Xu, Zhi-yi, Xu, Yang, Xie, Xiao-fang, Tian, Yin, Sui, Jun-hui, Sun, Yong, Lin, Da-sheng, Gao, Xing, Peng, Cheng, Fan, Yu-jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816336/ https://www.ncbi.nlm.nih.gov/pubmed/33468191 http://dx.doi.org/10.1186/s13020-021-00424-3 |
Ejemplares similares
-
Saponin accumulation in the seedling root of Panax notoginseng
por: Wang, Dong, et al.
Publicado: (2011) -
Pustular drug eruption due to Panax notoginseng saponins
por: Yin, ZhiQiang, et al.
Publicado: (2014) -
New dammarane-type triterpenoid saponins from Panax notoginseng saponins
por: Li, Qian, et al.
Publicado: (2020) -
Efficacy and Safety of Panax notoginseng Saponins in the Treatment of Adults With Ischemic Stroke in China: A Randomized Clinical Trial
por: Wu, Longfei, et al.
Publicado: (2023) -
Dammarane-type Triterpene Saponins from the Flowers of Panax notoginseng
por: Wang, Jing-Rong, et al.
Publicado: (2009)